Dobutamine bulk supplier for pharma manufacturers

Dobutamine 12.5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 12.5 mg/mL

Reference Brands: Dobutrex(US)

Dobutamine is an essential IV inotrope used in ICU and cardiac care for heart failure and shock. Available in 12.5 mg/mL strength, common brands include Dobutamina Hameln and Dobutamine Fresenius. It is widely supplied to hospitals and healthcare institutions through pharma B2B and critical care procurement channels.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Dobutamine? List it or send an offer →

Product Description: Dobutamine is a fast-acting inotropic agent used to treat acute heart failure and cardiogenic shock by enhancing cardiac output. Administered via intravenous infusion, it acts on beta-1 adrenergic receptors to improve myocardial contractility. Dobutamine is commonly available in 12.5 mg/mL concentration, supplied in 250 mg/20 mL and 500 mg/40 mL vials or ready-to-use infusion bags. Brands like Dobutamina Hameln and Dobutamine Fresenius are well-recognized in the EU, with various generics available in the US. Dobutamine is a critical care medication procured by hospitals, ICUs, and emergency departments, often listed in institutional tenders and group purchasing organizations.

Dobutamine — third party manufacturing & bulk supply

Dobutamine 12.5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dobutamine is supplied as Intravenous (IV) Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dobutamine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dobutamine →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Dobutamine is listed as Intravenous (IV) Injection in 12.5 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Dobutamine is referenced against Dobutrex(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.